Page last updated: 2024-11-13

agmatidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

agmatidine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

agmatidine : Cytidine in which the 2-keto group on the cytosine ring is substituted by the amino group of agmatine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID44593871
CHEBI ID64329
MeSH IDM0545889

Synonyms (11)

Synonym
agmatidine
CHEBI:64329
agm(2)c
n-(4-carbamimidamidobutyl)-4-imino-1-(beta-d-ribofuranosyl)-1,4-dihydropyrimidin-2-amine
Q4692957
rd252eb5w3 ,
n-(4-carbamimidamidobutyl)-4-imino-1-(beta-d-ribofuranosyl)-1,4-dihydro-2-pyrimidinamine
1221169-70-5
DTXSID701029783
guanidine, n-(4-((1,4-dihydro-4-imino-1-.beta.-d-ribofuranosyl-2-pyrimidinyl)amino)butyl)-
n-(4-((1,4-dihydro-4-imino-1-.beta.-d-ribofuranosyl-2-pyrimidinyl)amino)butyl)guanidine
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
cytidines
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's9 (100.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.32

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.32 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index5.53 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index3.00 (0.95)

This Compound (18.32)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (33.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (66.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]